Shareholders' Equity [Text Block] | Note 6-Shareholders' Equity Common Stock Our authorized capital stock consists of 75,000,000 shares of common stock, with a par value of $0.001 per share, and 10,000,000 preferred shares with a par value of $0.001 per share. On June 23, 2021, the Company issued 2,311,000 shares of common stock at a price of $4.50 per Common Share, for gross proceeds of $10,399,500, in connection with the initial tranche of a non-brokered private placement (“Private Placement”). As of June 30, 2021, the Company had received $6,496,034 in connection with the second tranche of the Private Placement, as further discussed in Note 7. The related 1,443,563 shares of common stock were not issued until July 2021. During the three months ended June 30, 2021, the Company also issued (i) 224,005 shares of common stock valued at $1,119,467 for investment in mineral properties (see Note 3 for further discussion), (ii) 45,563 shares of common stock valued at $223,259 for a settlement of debt (see Note 2 for further discussion), and (iii) 1,450,000 shares of common stock valued at $7,177,500 as bonus shares to directors, employees and consultants to the Company. For the three months ending June 30, 2021, the share-based compensation expense for the bonus shares was allocated $1,361,250 to exploration costs and $5,816,250 to general and administrative expenses. During the three months ended June 30, 2020, the Company issued 374,544 shares of common stock upon cashless exercise of stock options and warrants. At June 30, 2021, there were 60,227,899 shares of our common stock outstanding. Common Stock Options, Restricted Stock Units and Warrants On March 11, 2021, the Company's board of directors adopted a plan entitled the "2021 Stock Incentive Plan." The 2021 Stock Incentive Plan has a total of 6,250,000 Common Shares available to award to the Company's directors, executive officers and consultants. As of June 30, 2021, a total of 2,378,750 shares of our common stock remained available for future grants under the 2021 Stock Incentive Plan. On January 25, 2015, the Company's board of directors adopted a plan entitled the "2015 Omnibus Incentive Plan." The 2015 Omnibus Incentive Plan is no longer in effect and no further securities will be issued under the 2015 Omnibus Incentive Plan, other than in respect of 75,000 common stock purchase options that remain outstanding. Outstanding stock options under the 2021 Stock Incentive Plan have a term of five years. Outstanding stock options granted to third-party service providers generally vest over the period of the contract, which is typically one year. The Company recognized stock-based compensation related to issuance of stock options totaling $3,056,515 ($501,890 being allocated to exploration costs and $2,554,625 and being allocated to administrative expenses) during the three months ended June 30, 2021. No stock-based compensation was recognized by the Company during the three months ended June 30, 2020. On May 17, 2021, the Company granted 2,071,250 options to officer, directors and consultants. A summary of the Company's stock option activity and related information for the period ended June 30, 2021 is as follows: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (In Years) Aggregate Intrinsic Value Outstanding as of March 31, 2021 825,000 $ 1.77 4.61 $ 2,661,000 Options granted 2,071,250 4.76 4.88 497,100 Outstanding as of June 30, 2021 2,896,250 $ 3.91 4.80 $ 3,158,100 Options exercisable as of June 30, 2021 765,417 $ 4.32 3.84 During the three months ended June 30, 2021, we estimated the fair value of each stock option to have a weighted average grant date fair value of $3.39 per share on the date of grant using a Black Scholes valuation model. The weighted-average assumptions used to calculate the grant date fair value were as follows: exercise price of $4.76, risk-free interest rate of 0.95%, estimated volatility of 90%, dividend yield of 0%, and expected life of 5 years. As at June 30, 2021 the unrecognized compensation cost related to unvested options was $4,963,034. On June 4, 2021 the Company issued 1,050,000 restricted stock units ("RSU's") with a grant date fair value of $4.95 per share to certain directors, officers, employees and consultants vesting on June 4, 2022. The share-based compensation expense for the RSU's will be amortized monthly and allocated to exploration costs and general and administrative expenses. For the three months ending June 30, 2021, $52,890 and $317,343 were allocated to exploration costs and general and administrative expenses, respectively. There were no warrants outstanding as of June 30, 2021 and March 31, 2021. |